Cosmo Bio CoTSE:3386 -0.55%73 OCF Yield % is 8.28 as of Jul. 09, 2026, which is 2% below its 10-year median of 8.42. GuruFocus rates TSE:3386 with a GF Score™ of 73/100 and a GF Value™ of 円1,246.90 (Fairly Valued). The stock has 4 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, Cosmo Bio Co ranks better than 79.91% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Cosmo Bio Co's OCF Yield % or its related term are showing as below:
TSE:3386'
s OCF Yield % Range Over the Past 10 Years
Min: 1.17 Med: 8.42 Max: 17.43
Current: 8.28
During the past 13 years, the highest OCF Yield % of Cosmo Bio Co was 17.43%. The lowest was 1.17%. And the median was 8.42%.
TSE:3386's OCF Yield % is ranked better than 79.91% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.065
vs TSE:3386: 8.28
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Cosmo Bio Co OCF Yield % Related Terms
Cosmo Bio Co OCF Yield % Historical Data
* Premium members only.
The historical data trend for Cosmo Bio Co's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3386 vs TMO, DHR, IDXX: OCF Yield % Comparison
For the Diagnostics & Research subindustry, Cosmo Bio Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmo Bio Co OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Cosmo Bio Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Cosmo Bio Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmo Bio Co (TSE:3386) has a OCF Yield % of 8.28 as of Jul. 09, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Cosmo Bio Co and its competitors. This is near median its historical median of 8.42. Over the past decade, Cosmo Bio Co's OCF Yield % has ranged from 1.17 to 17.43. According to the industry distribution chart, Cosmo Bio Co ranks #43 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 20.1%.
Is Cosmo Bio Co's OCF Yield % too high?
Cosmo Bio Co's current OCF Yield % of 8.28 is near median its 10-year median of 8.42. Over the past 10 years, this metric has ranged from a low of 1.17 to a high of 17.43. The Medical Diagnostics & Research industry median OCF Yield % is 1.07. Cosmo Bio Co's value of 8.28 is 677.5% above this industry median. Based on the distribution chart, Cosmo Bio Co ranks #43 out of 214 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Cosmo Bio Co has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cosmo Bio Co's OCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Cosmo Bio Co ranks #43 out of 214 companies for OCF Yield %. This places Cosmo Bio Co in the top 20% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.07. Cosmo Bio Co's value of 8.28 is 677.5% above this benchmark. Historically, Cosmo Bio Co's own OCF Yield % has ranged from 1.17 to 17.43 over the past decade. While the company's 10-year median is 8.42 vs. the industry median of 1.07, Cosmo Bio Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.07, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cosmo Bio Co's current OCF Yield % of 8.28 is 677.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Cosmo Bio Co and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmo Bio Co's current OCF Yield % is 8.28, which is near median its own 10-year median of 8.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmo Bio Co stock overvalued right now?
Based on GuruFocus' analysis, Cosmo Bio Co (TSE:3386) is currently considered Fairly Valued. The stock's GF Value™ is 円1,246.90, compared to a current price of 円1,262.00 — trading 1.2% above its estimated fair value. The current OCF Yield % is 8.28, which is near median its 10-year median of 8.42 and 677.5% above the Medical Diagnostics & Research industry median of 1.07. Cosmo Bio Co's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Cosmo Bio Co (TSE:3386), the current OCF Yield % is 8.28 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmo Bio Co (TSE:3386) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmo Bio Co stock appears to be overvalued.
The current stock price of 円1,262.00 is trading 1.2% above its estimated GF Value™ of 円1,246.90.
GuruFocus considers Cosmo Bio Co to be Fairly Valued.
Key valuation signals for TSE:3386:
OCF Yield %: 8.28 (near median its 10-year median of 8.42)
GF Value™: 円1,246.90 vs. price of 円1,262.00 (1.2% above fair value)
Industry Position: 677.5% above the Medical Diagnostics & Research median (#43 of 214)
No single metric tells the full story. See the TSE:3386 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes the purchase of reagents, instruments, and clinical test drugs for research in life science and domestic sales.
73GF Score
Get the complete analysis for TSE:3386
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3386 has been successfully added to your 
